MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
AGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Agenus (AGEN) Ownership - Who owns Agenus?

Agenus Inc is a clinical-stage biotechnology company focused on discovering and developing immunotherapies for cancer and infectious diseases... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
81
Web
https://www.agenusbio.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
126.59M
P/E Ratio
1.48
Total Cash
35M
Projected Growth
N/A
Total Debt
41.07M
Revenue
123.87M
Risk (Beta)
1.87
Dividend Yield
N/A
Total Cash/Share
0.84
Total Debt/Equity
14.79
Revenue/Share
3.73 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
AGEN
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for AGEN
A.I. Advisor
published General Information

General Information

a developer of technologies to treat cancers and infectious diseases

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
3 Forbes Road
Phone
+1 781 674-4400
Employees
81
Web
https://www.agenusbio.com